Bayban »

Gilead Sciences shares owned by Bayban

Quarter-by-quarter ownership of Gilead Sciences (GILD) shares owned by Bayban from 13F filings

Historical chart of Bayban investment in Gilead Sciences

Tip: Access up to 7 years of quarterly data

All positions including Gilead Sciences held by Bayban consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gilead Sciences by Bayban

Quarter filed Position value Share count Share price at filing
2025-12-31 $108k 879 122.74

More positions owned by Bayban

UnitedHealth (UNH)
IShares Core S&P 500 ETF Core S&p500 Etf (IVV)
Vanguard Total Stock Market ETF Total Stk Mkt (VTI)
Apple (AAPL)
US Bancorp Com New (USB)
Exxon Mobil Corporation (XOM)
Vanguard FTSE Developed Markets ETF Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
3M Company (MMM)
Johnson & Johnson (JNJ)
IShares Trust Russell 1000 Growth ETF Rus 1000 Grw Etf (IWF)
IShares Core MSCI EAFE ETF Core Msci Eafe (IEFA)
Invesco QQQ Trust Series 1 ETF Unit Ser 1 (QQQ)
Xcel Energy (XEL)
Vanguard Dividend Appreciation ETF Div App Etf (VIG)

View all positions for Bayban

Top funds holding Gilead Sciences

BlackRock
Vanguard Group
FMR
State Street Corporation
Capital World Investors
Geode Capital Management
Dodge & Cox
Wellington Management Company
Capital Research Global Investors
Norges Bank Investment Management
Jpmorgan Chase & Co
Invesco
Bank of New York Mellon
Northern Trust
Ubs Global Asset Management Americas

View all funds holding Gilead Sciences